Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 966

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 946

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 935

Subacute Myleo-Optic Neuropathy- Case Report

Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS

Issue: 1998, Volume 4 - Issue 3-4
0 869

Therapentic Advances In Multiple Sclerosis

Egemen İDİMAN

Issue: 1998, Volume 4 - Issue 1-2
0 872

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 978

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 917

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 962

Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN

Issue: 1995, Volume 1 - Issue 1
0 935

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 1063

The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment

Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil

DOI: 10.55697/tnd.2025.216

Issue: 2025, Volume 31 - Issue 1
1961 1744

Distinguishing Alzheimer's disease from Parkinson's disease dementia using Enhanced Cued Recall test subscores

Ezgi Yetim, Ezgi Demirel, Ayse Akyay, Gul Yalcin Cakmakli, Esen Saka

DOI: 10.55697/tnd.2025.136

Issue: 2025, Volume 31 - Issue 1
2111 1959

Investigation of mutations in early-onset Parkinson’s disease through next-generation sequencing analysis

Tuba Sözen Turk, Ahmet Acarer, Asude Durmaz, Burak Durmaz, Figen Gokcay, Zafer Colakoglu, Haluk Akın, Ozgur Cogulu, Ayca Aykut

DOI: 10.55697/tnd.2025.163

Issue: 2025, Volume 31 - Issue 2
3494 2722

Efficacy and safety of intravenous thrombolytic therapy in acute ischemic stroke: Predictors of good prognosis and outcomes of the elderly population

Burak Gürel, Vedat Ali Yürekli

DOI: 10.55697/tnd.2026.578

Issue: 2026, Volume 32 - Issue 1
713 597

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
836 511

Global infodemiological trends in Parkinson’s disease-associated sleep disorders: Long-term digital impact of the COVID-19 pandemic

Esra Demir Ünal, Selim Selçuk Çomoğlu

DOI: 10.55697/tnd.2026.611

Issue: 2026, Volume 32 - Issue 1
803 571

Rescue mechanical thrombectomy for large vessel occlusion during endovascular treatment of aneurysmal subarachnoid hemorrhage: A case report

Martin Vasilev, Vladina Dimitrova-Kirilova, Nora Ivanova, Tihomir Drenski, Georgi Todorov, Chavdar Bachvarov, Mihael Tsalta-Mladenov

DOI: 10.55697/tnd.2026.568

Issue: 2026, Volume 32 - Issue 1
656 489